Thomasville National Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Thomasville National Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38,459	Closed	-$146K	–	232
2021 Q1	$146K	Buy	+38,459	New	+$146K	0.03%	176

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Thomasville National Bank's BMY.RT Position: Q2 2021 in Review

Thomasville National Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2021, closing a stake of 38,459 shares — an estimated $146K sold.

Thomasville National Bank first reported a position in BMY.RT in Q1 2021 and held it in 1 quarter. The position peaked at $146K in Q1 2021. 8 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2021.

Thomasville National Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2021 after selling out during the quarter.
Thomasville National Bank sold 38,459 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2021, an estimated $146K.
Thomasville National Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2021 and held it in 1 quarter.
Thomasville National Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $146K in Q1 2021.
8 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2021.

Based on Thomasville National Bank's 13F filing for Q2 2021, filed 2 Jul 2021.